BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17403721)

  • 1. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
    Ray KK; Cannon CP; Morrow DA; Kirtane AJ; Buros J; Rifai N; McCabe CH; Gibson CM; Braunwald E
    Eur Heart J; 2007 Apr; 28(7):806-13. PubMed ID: 17403721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial.
    Bhadriraju S; Ray KK; DeFranco AC; Barber K; Bhadriraju P; Murphy SA; Morrow DA; McCabe CH; Gibson CM; Cannon CP; Braunwald E
    Am J Cardiol; 2006 Jun; 97(11):1573-7. PubMed ID: 16728216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
    Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome].
    Sanchís J; Bodí V; Llácer A; Facila L; Martínez-Brotons A; Insa L; Chorro FJ
    Rev Esp Cardiol; 2004 May; 57(5):382-7. PubMed ID: 15151771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
    Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
    Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes.
    Ainla T; Baburin A; Teesalu R; Rahu M
    Diabet Med; 2005 Oct; 22(10):1321-5. PubMed ID: 16176190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).
    Moghbeli N; Kirtane AJ; Ray KK; Murphy SA; Gibson CM; Braunwald E; Cannon CP;
    Am J Cardiol; 2005 Sep; 96(5):635-8. PubMed ID: 16125484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.
    Ahmed S; Cannon CP; Giugliano RP; Murphy SA; Morrow DA; Antman EM; Braunwald E; Gibson CM
    Int J Cardiol; 2008 Dec; 131(1):105-12. PubMed ID: 18187215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.
    Gibson CM; Dumaine RL; Gelfand EV; Murphy SA; Morrow DA; Wiviott SD; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    Eur Heart J; 2004 Nov; 25(22):1998-2005. PubMed ID: 15541835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL; Morrow DA; de Lemos JA; Mohanavelu S; Cannon CP; Sabatine MS
    J Am Coll Cardiol; 2008 Jun; 51(25):2422-9. PubMed ID: 18565400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
    de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
    J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.